BC
GILD icon

Burleson & Co’s Gilead Sciences GILD Stock Holding History

Burleson & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$42.9K Hold
500
– – 0.01% 183
2022
Q3 		$31K Sell
500
-14
-3% -$883 0.01% 221
2022
Q2 		$32K Buy
514
+14
+3% +$867 0.01% 203
2022
Q1 		$30K Hold
500
– – ﹤0.01% 216
2021
Q4 		$36K Hold
500
– – 0.01% 207
2021
Q3 		$35K Hold
500
– – 0.01% 207
2021
Q2 		$34K Sell
500
-169
-25% -$11.3K 0.01% 215
2021
Q1 		$43K Buy
+669
New +$43.1K 0.01% 188

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Burleson & Co's GILD Position: Q4 2022 in Review

Burleson & Co held its Gilead Sciences (GILD) position steady in Q4 2022 at 500 shares worth $42.9K. The position accounts for 0.01% of the portfolio, ranked #183.

Burleson & Co first reported a position in GILD in Q1 2021 and has held it in 8 quarters since. The position peaked at $43K in Q1 2021. 1,768 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Burleson & Co held 500 shares of Gilead Sciences worth $42.9K as of Q4 2022.
  • Burleson & Co left its Gilead Sciences share count unchanged in Q4 2022.
  • Gilead Sciences made up 0.01% of Burleson & Co's portfolio in Q4 2022, its #183 holding.
  • Burleson & Co first reported a position in Gilead Sciences in Q1 2021 and has held it in 8 quarters since.
  • Burleson & Co's Gilead Sciences position peaked at $43K in Q1 2021.
  • 1,768 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.